GeneDx Holdings Corp. (WGS) Investment Research Dashboard
About GeneDx Holdings Corp. (WGS) stock analysis
Get live WGS stock price $61.88, comprehensive GeneDx Holdings Corp. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time WGS stock data and investment insights.
Loading chart data...
GeneDx Holdings Corp. (WGS) Overview
GeneDx Holdings Corp. (WGS) is a publicly traded company in the Healthcare sector , specifically within the Medical - Healthcare Information Services industry . As of the latest trading session, WGS trades at $61.88 with a market capitalization of 1.84B . Over the past 52 weeks, WGS has traded between $32.21 and $170.87 , with the current price positioned at approximately 21% of this range . Th...
Key Takeaways
- Operates in the Healthcare sector (Medical - Healthcare Information Services)
- Market cap: 1.84B
- Current price: $61.88
- 52-week range: $32.21 - $170.87
- P/E ratio: 72.80
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophistica...
Company Information
- CEO
- Katherine A. Stueland
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 1300
Contact Information
- Website
- http://www.genedx.com
- Address
- North Tower
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 72.8)
✓ Higher growth potential with elevated volatility (Beta: 1.91)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for GeneDx Holdings Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for GeneDx Holdings Corp.
- ⚠Investors should consider how GeneDx Holdings Corp. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 72.8) requires strong growth to justify
Market Cap
1.84B
P/E Ratio (TTM)
72.80
Beta
1.91
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare WGS with peer companies:
- Price
- $83.86+0.01% (1D)
- Market cap
- 8.88B
- Price
- $75.25+0.19% (1D)
- Market cap
- 5.82B
- Price
- $38.90-2.97% (1D)
- Market cap
- 7.99B
- Price
- $106.16-3.53% (1D)
- Market cap
- 8.73B
- Price
- $27.98-7.41% (1D)
- Market cap
- 3.27B
- Price
- $22.48+3.07% (1D)
- Market cap
- 3.53B
- Price
- $31.40+10.80% (1D)
- Market cap
- 8.14B
- Price
- $24.83+0.65% (1D)
- Market cap
- 3.13B
- Price
- $76.29+2.71% (1D)
- Market cap
- 2.64B
- Price
- $33.86-2.90% (1D)
- Market cap
- 3.93B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.